Skip to main content

Mycoplasma Testing in Cell Culture

Quick Facts

FeatureInformation
PurposeDetection of mycoplasma contamination in cell cultures
OrganismWall-less bacteria (Class Mollicutes)
Detection FrequencyMonthly (recommended)
Common Detection MethodPCR
Biosafety ImpactEssential Quality Control
Applicable ToCell lines, primary cells, stem cells, organoids, cell banks

Overview

Mycoplasma contamination is one of the most common and serious quality control issues in cell culture laboratories. Unlike bacterial or fungal contamination, mycoplasma infections are usually invisible, do not cause media turbidity, and may remain undetected for extended periods.

Because contamination can profoundly alter cell physiology and experimental outcomes, routine mycoplasma testing is considered an essential component of good cell culture practice.


What are Mycoplasmas?

Mycoplasmas are extremely small bacteria belonging to the class Mollicutes.

Unlike most bacteria, they:

  • Lack a cell wall
  • Grow slowly
  • Are resistant to many common antibiotics
  • Are generally invisible under routine light microscopy
FeatureDescription
Size0.1-0.8 μm
Cell WallAbsent
Growth RateSlow
Microscopic VisibilityUsually not visible
Antibiotic ResistanceResistant to many cell wall-targeting antibiotics

Why Mycoplasma Testing Matters

Mycoplasma contamination can alter numerous cellular processes, including:

  • Cell proliferation
  • Apoptosis
  • Differentiation
  • Cellular metabolism
  • Signal transduction
  • Immune responses
  • Gene expression
  • Protein expression

These changes can lead to:

  • False biological phenotypes
  • Poor experimental reproducibility
  • Invalid research conclusions

Common Sources of Contamination

Typical sources include:

  • Cross-contaminated cell lines
  • Laboratory personnel
  • Contaminated sera or reagents
  • Poor aseptic technique
  • Shared culture media and pipettes

Why Detection is Difficult

Unlike bacterial contamination, mycoplasma infection usually does not produce obvious visual changes.

Typical characteristics include:

  • Clear culture medium
  • Normal pH indicator color
  • Continued cell growth
  • No visible turbidity

Possible indirect signs include:

  • Reduced proliferation
  • Increased cell death
  • Morphological abnormalities
  • Experimental variability
  • Unexpected differentiation failure

When Should Cells Be Tested?

Routine screening is recommended throughout the cell culture workflow.

Time PointRecommendation
Routine cultureEvery 4 weeks
Before cryopreservationRequired
After thawingRecommended
Before distributionRequired
Before major experimentsRecommended

Examples of critical experiments include:

  • RNA-seq
  • Proteomics
  • Drug screening
  • Stem cell differentiation
  • Genome editing

Detection Methods

MethodSensitivitySpeedTypical Use
PCRHighFastRoutine testing
qPCRVery HighFastClinical and GMP laboratories
DNA Fluorescent StainingModerateFastRapid screening
Culture-Based DetectionVery HighSlowConfirmatory testing
Luminescence AssaysHighVery FastRoutine laboratory screening

PCR remains the most widely adopted method because it combines high sensitivity with relatively rapid turnaround.


Recommended Testing Strategy

For most research laboratories:

Routine Screening

PCR or Luminescence Assay

If Positive

Confirm by PCR (if required)

Appropriate corrective action


Interpreting Results

Negative Result

  • No detectable mycoplasma contamination
  • Continue routine monitoring

Positive Result

  • Culture considered contaminated
  • Immediate corrective action required
  • Prevent spread to other cultures

Prevention Strategies

Good laboratory practices remain the most effective prevention strategy.

Recommended practices include:

  • Routine monthly testing
  • Quarantine newly received cell lines
  • Separate validated and unverified cultures
  • Use dedicated reagents when possible
  • Maintain strict aseptic technique
  • Perform regular surface disinfection

Importance for Stem Cell Research

Routine testing is particularly important for:

  • Human iPSCs
  • Embryonic stem cells
  • Organoids
  • Neural stem cells
  • Gene-edited cell lines

Contamination may alter:

  • Pluripotency
  • Differentiation efficiency
  • Gene expression
  • Genome editing outcomes
  • Omics datasets

Untested cultures should never be used for:

  • Cell banking
  • CRISPR editing
  • Clone generation
  • Clinical or translational studies

Laboratory Quality Control

A comprehensive quality control program should include:

  • Monthly mycoplasma screening
  • Testing before cryopreservation
  • Testing after thawing
  • Testing before cell distribution
  • Testing before publication-quality experiments

Common Problems

ProblemPossible CauseRecommended Solution
Repeated positive resultsCross-contaminationImprove segregation and replace contaminated stocks
False positivesSample contaminationRepeat testing with confirmatory assay
False negativesLow organism loadRepeat testing using PCR-based methods

Best Practices

  • Test cultures every month
  • Verify cultures before cryopreservation
  • Test all newly acquired cell lines before routine use
  • Confirm cultures are mycoplasma-negative before publication
  • Never establish Master Cell Banks from untested cultures

Related SOPs

  • SOP: PCR-Based Mycoplasma Detection
  • SOP: MycoAlert® Luminescence Assay
  • SOP: DAPI/Hoechst Mycoplasma Screening
  • SOP: Mycoplasma Decontamination
  • SOP: Cell Line Quarantine

References

  • Uphoff CC, Drexler HG. Detection of Mycoplasma Contamination in Cell Cultures. Current Protocols in Molecular Biology (2014).
  • Young L et al. Detection and Control of Mycoplasma Contamination in Cell Cultures. Cytotechnology (2010).
  • International Cell Line Authentication Committee (ICLAC) Recommendations.
  • Freshney RI. Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications.